Mechanisms and countermeasures in relapse of relapsed/refractory non-Hodgkin lymphoma after treatment of CD19 chimeric antigen receptor T cells

Lymphoma
15/06/2020

Wang SY, et al. Zhonghua Xue Ye Xue Za Zhi 2020.

NO ABSTRACT